Related Experiment Video

Updated: May 8, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Which newborns missed the hepatitis B birth dose vaccination among U.S. children?

Zhen Zhao1, Trudy V Murphy

  • 1National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mail Stop A19, Atlanta, GA 30333, USA.

Preventive Medicine
|August 31, 2013
PubMed

Insights

Nearly 40% of U.S. children missed the hepatitis B birth dose vaccine. Lack of state universal vaccine policies and no health insurance are key factors. Interventions are needed.

Area of Science:

  • Public Health
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Hepatitis B birth dose vaccination is crucial for preventing perinatal hepatitis B virus transmission.
  • Understanding vaccination gaps is essential for public health strategies.

Purpose of the Study:

  • To determine the prevalence of missed hepatitis B birth dose vaccinations in U.S. children.
  • To identify socio-demographic factors associated with non-receipt of this critical vaccine.

Main Methods:

  • Utilized a national representative sample of 17,053 U.S. children aged 19-35 months from the 2009 National Immunization Survey.
  • Employed complex sample survey methods, including categorical data analysis and multivariable logistic regression.

Main Results:

  • A significant 39.2% of children did not receive the hepatitis B birth dose vaccine.
  • Non-receipt was associated with residing in states lacking universal vaccine supply policies, lacking health insurance, and having a single vaccination provider.

Conclusions:

  • Lack of state universal hepatitis B vaccine supply policies and absence of health insurance are significant, modifiable risk factors for missed birth doses.
  • Targeted interventions addressing these factors are recommended to improve vaccination rates and prevent hepatitis B infections.
Abstract

Keywords:
ACIPACIP recommendationsAdvisory Committee on Immunization PracticesHepatitis B vaccineNon-receipt of the birth doseRisk factorsUniversal supply policy

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...